Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
The Journal of Pathology|May 27, 2015
Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesotheliomaViktoria Laszlo, Mir Alireza Hoda, Tamas Garay, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 2, 2024
Telomere transcripts act as tumor suppressor and are associated with favorable prognosis in colorectal cancer with low proliferating cell nuclear antigen expressionPhilip Kienzl, Abigail J Deloria, Monika Hunjadi, et al.
Carcinogenesis|April 11, 2018
FGF2 and EGF induce epithelial-mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signalKarin Schelch, Christina Wagner, Sonja Hager, et al.
Cancer Research|October 30, 2025
Multi-omics Profiling of T-cell Leukemia and Lymphoma Enables Targeted Therapeutic DiscoveryAleksandr Ianevski, Kristen Nader, Julia Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2020
Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma SubgroupChristine Pirker, Agnes Bilecz, Michael Grusch, et al.
Acta Neuropathologica Communications|April 28, 2022
Fibroblast growth factor receptor 4 promotes glioblastoma progression: a central role of integrin-mediated cell invasivenessLisa Gabler, Carola Nadine Jaunecker, Sonja Katz, et al.
Hemasphere|December 2, 2024
Dual specific STAT3/5 degraders effectively block acute myeloid leukemia and natural killer/T cell lymphomaDaniel Pölöske, Helena Sorger, Anna Schönbichler, et al.
Acta Neuropathologica|May 28, 2021
Targeting fibroblast growth factor receptors to combat aggressive ependymomaDaniela Lötsch, Dominik Kirchhofer, Bernhard Englinger, et al.
Neuro-Oncology|November 18, 2024
Alternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimensAnna Laemmerer, Christian Lehmann, Lisa Mayr, et al.
EMBO Molecular Medicine|November 7, 2022
Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphomaHelena Sorger, Saptaswa Dey, Pablo Augusto Vieyra-Garcia, et al.
Pageof 9